Introduction
Depressive disorder is a fairly common problem among different groups of the population. However, there are vulnerable categories that belong to high-risk groups. These categories include teenagers, older adults, dementia patients, and pregnant women whose mental health can be influenced by various factors. The choice of depression treatment for these people depends on their age and overall health. Therefore, this paper evaluates drug treatment options for depressive disorder in pregnant women.
Causes
The causes of depression disorder in pregnant women might be different. First, pregnancy comes with significant hormonal fluctuations, which can affect mood regulation. Hormones such as estrogen and progesterone can influence neurotransmitters in the brain, potentially contributing to mood disorders (Lilliecreutz et al., 2021).
Secondly, physical changes in the body, childbirth, and subsequent raising of a child can lead to stress and the development of symptoms of depression. The symptoms may be exacerbated by a lack of social support and strained relationships with family and friends. Finally, the tendency to depression, like many other mental disorders, is genetic (Zemestani & Fazeli Nikoo, 2020). If a woman has a family history of depression, the disorder may develop during pregnancy and the postpartum period due to significant stress.
Symptoms
Identifying symptoms of depression in pregnant women can be more complicated than in other people. It occurs because changes in a woman’s hormonal levels can lead to significant mood swings and emotional changes (Lilliecreutz et al., 2021). However, the hallmark of depressive disorder symptoms is that they are persistent and worsen without proper help.
The most common symptoms include persistent feelings of sadness, hopelessness, or despondency, loss of interest in activities that were once enjoyable, and difficulty concentrating (Lilliecreutz et al., 2021). In addition, depression may be accompanied by decreased appetite, weight loss, insomnia, and constant fatigue. In severe conditions, patients experience physical symptoms such as headaches and may also have thoughts of self-harm or suicide (Lilliecreutz et al., 2021). Self-diagnosis of depression may be complicated because some of the symptoms are characteristic of pregnancy in general.
Diagnosis
Diagnosing depression in pregnant women requires a thorough assessment of her condition, considering the specific aspects associated with pregnancy. It implies active interaction between mental health professionals and obstetricians. A comprehensive assessment includes a general assessment of the patient’s health, a psychiatric assessment to assess the severity of depressive symptoms and monitor changes over time, as well as an assessment of risk factors and a family medical history (Zemestani & Fazeli Nikoo, 2020). These steps are standard for all patients when diagnosing depression.
However, given the special situation of women, obstetricians and the antenatal care team are actively involved in psychiatric assessment. This helps ensure that any physical symptoms or illnesses associated with pregnancy, such as fatigue and changes in appetite, are appropriately assessed (Lilliecreutz et al., 2021). This can help rule out health problems that may mimic or worsen depression. In addition, this collaboration allows assessment of maternal and fetal safety, especially if a woman has thoughts of self-harm, fetal harm, or suicide (Lilliecreutz et al., 2021). Thus, to diagnose depression in pregnant women, it is necessary to consider many factors that may influence the patient’s condition.
Treatment
Drug treatment options for depressive disorder in pregnancy are limited due to maternal and fetal safety concerns. The choice of medication and the timing of its use during pregnancy should be individualized, and the pregnant woman should be fully informed about the potential benefits and risks. Some of the most commonly used types of drugs prescribed to treat depression during pregnancy are Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Selective Serotonin Reuptake Inhibitors (SSRIs), and Bupropion (Table 1).
Table 1 – Treatment options for pregnant women with depressive disorder
Prescription Examples
- Sertraline (Zoloft) 50 mg once daily. Take one tablet by mouth daily. Dispense 30 tablets.
- Fluoxetine (Prozac) 20 mg once daily. Take one capsule by mouth daily. Dispense 30 capsules.
- Bupropion (Wellbutrin) 150 mg extended-release tablet once daily. Take one extended-release tablet by mouth daily. Dispense 30 extended-release tablets.
Prescription Considerations
Determining drug treatment for pregnant women requires considering various factors. The choice of medications should be based on an individual assessment of the woman’s specific symptoms, previous treatment history, and any potential contraindications (Payne, 2021). This includes a comprehensive assessment of the patient’s condition, as well as a joint decision between the woman and the doctor regarding the use of medications.
Additionally, during pregnancy, dosages of any psychiatric medications are kept to a minimum to reduce risks while still effectively impacting a woman’s mental health (Payne, 2021). Additionally, the entire process of taking and stopping medications must be under the supervision of a doctor. Antidepressants can be addictive, and abruptly stopping them can trigger withdrawal symptoms and worsen depression (Schoretsanitis et al., 2020). The patient should be warned about all these considerations before starting medication.
Treatment of mental disorders involves ongoing monitoring and assessment of symptoms. However, for pregnant women taking medications to treat a depressive disorder, monitoring should be done with redoubled attention, assessing not only the condition of the mother but also the fetus. Pregnant women should be monitored for potential side effects of antidepressants.
Common side effects may include nausea, dizziness, and mood changes (Schoretsanitis et al., 2020). In addition to side effects, it is essential to monitor the success of treatment, assess progress, and adjust the treatment plan as needed. Additionally, fetal monitoring is crucial for assessing the baby’s well-being and development, particularly if the mother is taking medications during pregnancy (Payne, 2021). Antidepressants can negatively affect various body systems, which can harm the fetus or affect its development.
In addition to medical considerations, other aspects are essential to consider when working with pregnant women with depressive disorder. It is necessary to understand the legal costs, including state and local laws, regarding the administration of psychiatric medications to pregnant women (Payne, 2021). Additionally, it is essential to act in accordance with ethical standards, informing patients about their options and associated risks, and allowing them to make informed decisions regarding their treatment. It is crucial to consider the patient’s cultural context, values, and beliefs, which may influence treatment and medication decisions.
To receive more detailed information and expert advice, women can utilize community resources for support and guidance. For example, appropriate advice can be obtained from obstetricians or maternal-fetal medicine professionals in local health facilities. Furthermore, a woman can contact a mental health professional, informing them about her pregnancy and its progress in advance. Thanks to this, women will receive comprehensive advice and help in treating depression. Finally, the community has support groups and organizations whose activities are aimed at providing comprehensive assistance to mothers, including in cases of mental disorders.
Conclusion
In conclusion, depressive disorder is a serious mental illness that requires professional intervention for effective diagnosis and treatment. In pregnant women, making a diagnosis can be challenging because many symptoms may overlap with typical signs of pregnancy. Moreover, drug treatment options for depression in pregnant women are limited due to their condition and the risk of harm to the fetus. Therefore, the choice of medications should consider all medical, legal, and ethical issues when the patient is aware of the risks and independently makes decisions from the proposed options.
References
Juniur. (n.d.). Pregnant woman in prepartum depression[Picture].
Lilliecreutz, C., Josefsson, A., Mohammed, H., Josefsson, A., & Sydsjö, G. (2021). Mental disorders and risk factors among pregnant women with depressive symptoms in Sweden: A case-control study. Acta Obstetricia et Gynecologica Scandinavica, 100(6), 1068–1074.
Payne J. L. (2021). Psychiatric medication use in pregnancy and breastfeeding. Obstetrics And Gynecology Clinics of North America, 48(1), 131–149.
Pch.Vector. (n.d). Doctor consulting pregnant woman in office[Picture].
Schoretsanitis, G., Spigset, O., Stingl, J. C., Deligiannidis, K. M., Paulzen, M., & Westin, A. A. (2020). The impact of pregnancy on the pharmacokinetics of antidepressants: A systematic critical review and meta-analysis. Expert Opinion on Drug Metabolism & Toxicology, 16(5), 431–440.
Zemestani, M., & Fazeli Nikoo, Z. (2020). Effectiveness of mindfulness-based cognitive therapy for comorbid depression and anxiety in pregnancy: a randomized controlled trial. Archives Of Women’s Mental Health, 23(2), 207–214.